[go: up one dir, main page]

AU2003276494A1 - Functional sites - Google Patents

Functional sites

Info

Publication number
AU2003276494A1
AU2003276494A1 AU2003276494A AU2003276494A AU2003276494A1 AU 2003276494 A1 AU2003276494 A1 AU 2003276494A1 AU 2003276494 A AU2003276494 A AU 2003276494A AU 2003276494 A AU2003276494 A AU 2003276494A AU 2003276494 A1 AU2003276494 A1 AU 2003276494A1
Authority
AU
Australia
Prior art keywords
functional sites
sites
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276494A
Other versions
AU2003276494A8 (en
Inventor
Michael Mcarthur
Peter J. Sabo
John A. Stamatoyannopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regulome Corp
Original Assignee
Regulome Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regulome Corp filed Critical Regulome Corp
Publication of AU2003276494A8 publication Critical patent/AU2003276494A8/en
Publication of AU2003276494A1 publication Critical patent/AU2003276494A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003276494A 2002-06-13 2003-06-13 Functional sites Abandoned AU2003276494A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38791002P 2002-06-13 2002-06-13
US38788702P 2002-06-13 2002-06-13
US60/387,910 2002-06-13
US60/387,887 2002-06-13
PCT/IB2003/004491 WO2004005458A2 (en) 2002-06-13 2003-06-13 Functional sites

Publications (2)

Publication Number Publication Date
AU2003276494A8 AU2003276494A8 (en) 2004-01-23
AU2003276494A1 true AU2003276494A1 (en) 2004-01-23

Family

ID=29739965

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003245488A Abandoned AU2003245488A1 (en) 2002-06-13 2003-06-13 Functional sites
AU2003276494A Abandoned AU2003276494A1 (en) 2002-06-13 2003-06-13 Functional sites

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2003245488A Abandoned AU2003245488A1 (en) 2002-06-13 2003-06-13 Functional sites

Country Status (2)

Country Link
AU (2) AU2003245488A1 (en)
WO (2) WO2004005458A2 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121313A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US20040019915A1 (en) 2002-04-01 2004-01-29 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
JP2006516193A (en) 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド Rapid identification of pathogens in humans and animals
US8046171B2 (en) 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8394945B2 (en) 2003-09-11 2013-03-12 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US7365058B2 (en) 2004-04-13 2008-04-29 The Rockefeller University MicroRNA and methods for inhibiting same
ES2641832T3 (en) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Mass spectrometry with selective ion filtration by setting digital thresholds
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
CA2593086A1 (en) * 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
US20060205040A1 (en) 2005-03-03 2006-09-14 Rangarajan Sampath Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
WO2007014045A2 (en) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
CA2649250A1 (en) 2006-04-11 2007-10-25 Eisai R & D Management Co., Ltd. Dopaminergic neuron progenitor cell marker 187a5
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
US8871471B2 (en) 2007-02-23 2014-10-28 Ibis Biosciences, Inc. Methods for rapid forensic DNA analysis
WO2008113773A2 (en) * 2007-03-16 2008-09-25 Biorigen S.R.L. Gene expression regulation technology and noncoding rnas for diagnosis and therapy
US7695916B2 (en) * 2007-03-22 2010-04-13 Celera Corporation Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
AU2009275110B2 (en) * 2008-07-25 2012-08-16 Infocom Corporation Novel oncogene NRF2
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
US8148163B2 (en) 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
WO2010033599A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
CA2742531A1 (en) * 2008-11-04 2010-05-14 Idera Pharmaceuticals, Inc. Modulation of toll-like receptor 5 expression by antisense oligonucleotides
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
US8637642B2 (en) 2010-09-29 2014-01-28 Seattle Genetics, Inc. Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
WO2013015457A1 (en) 2011-07-27 2013-01-31 Kyoto University Novel markers for dopaminergic neuron progenitor cells
WO2015024017A2 (en) * 2013-08-16 2015-02-19 President And Fellows Of Harvard College Rna polymerase, methods of purification and methods of use
KR102500531B1 (en) 2014-09-04 2023-02-17 메모리얼 슬로안 케터링 캔서 센터 Globin gene therapy for treating hemoglobinopathies
US10450572B2 (en) * 2016-08-12 2019-10-22 Regents Of The University Of Minnesota Androgen receptor variant inhibitors and methods of using
AU2019392090A1 (en) 2018-12-03 2021-06-17 Agensys, Inc. Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
CN114864002B (en) * 2022-04-28 2023-03-10 广西科学院 A method for identifying transcription factor binding sites based on deep learning
WO2025151744A1 (en) * 2024-01-10 2025-07-17 University Of Tennessee Research Foundation Improved globin and other lentiviral vectors for gene therapy
CN120927886A (en) * 2024-03-15 2025-11-11 深圳市药品检验研究院（深圳市医疗器械检测中心） Digital thin-layer chromatography detection analysis model of Xinning tablet and establishment method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002029086A2 (en) * 2000-10-02 2002-04-11 Bayer Corporation Nucleic acid sequences differentially expressed in cancer tissue

Also Published As

Publication number Publication date
WO2004005458A3 (en) 2007-12-21
AU2003245488A8 (en) 2010-02-11
WO2004005458A2 (en) 2004-01-15
AU2003245488A1 (en) 2003-12-31
WO2003106635A9 (en) 2010-01-21
AU2003276494A8 (en) 2004-01-23
WO2003106635A2 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003245488A1 (en) Functional sites
AU2002335152A1 (en) Robot-phone
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003298556A1 (en) Functional sites
AU2002368348A1 (en) Electrosomatogram
AU2002318053A1 (en) Suplier
AU2002341221A1 (en) Honey-brandy
AU2002348964A1 (en) Snowbike
AU2002344387A1 (en) Multifunction-pillow
AU2002100482A4 (en) Tail-gate-ezy
AU2002100655A4 (en) Armamulch
AU2002100602A4 (en) Bonsystem
AU2002100541A4 (en) Backmate
AU2002100280A4 (en) Proshoe
AU2002100747A4 (en) Powersell
AU2002100739A4 (en) Neuramax
AU2002100026A4 (en) Disc400
AU2002100510A4 (en) Bottlenecker
AU2002100508A4 (en) Photocard
AU2002100468A4 (en) Flexi-edger
AU2002100498A4 (en) Linline
AU2002100031A4 (en) earliPay
AU2002100160A4 (en) Oxidirator
AU2002100957A4 (en) Sluggit
AU2002950535A0 (en) Austraila Extension

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase